Across L/P 8

NRNP 6675 WK 9

Choose one of the two following specific populations below and select specific disorder from the DSM-5 to use: Pregnant women OR Older adults.

A. Based on your selection for either pregnant women or older adults:

Recommend one FDA-approved drug (use a credible scholarly resource to support)

Recommend one off-label drug (use a credible scholarly resource to support)

Recommend one nonpharmacological intervention for treating (use a credible scholarly resource to support)

B. Based on your selection for either pregnant women or older adults:

Explain the risk assessment you would use to inform your treatment decision-making.

Explain the risks and benefits of the FDA-approved medicine.

Explain the risks and benefits of the off-label drug.

C. Based on your selection for either pregnant women or older adults:

Explain whether clinical practice guidelines exist for this disorder.

If clinical practice guidelines exist for the diagnosis, use them to justify your recommendations.

If clinical practice guidelines does not exist for the diagnosis, explain what information you would need to take into consideration.

D. Support your reasoning with at least three current, credible scholarly resources from the year 2018-2023.

Choose one of the two following specific populations : either pregnant women or older adults. Then, select a specific disorder from the  DSM-5-TR to use.

Use the Walden Library to research evidence-based treatments for your selected disorder in your selected population (either older adults or pregnant women). You will need to recommend one FDA-approved drug, one non-FDA-approved “off-label” drug, and one nonpharmacological intervention for treating the disorder in that population.

Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your chosen disorder in older adults or pregnant women.

Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?

Explain whether clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.

Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder. References should be within 2018-2023.